4.6 Article

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

Journal

FRONTIERS IN GENETICS
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fgene.2017.00021

Keywords

Pax6; dedifferentiation; reprogramming; beta cell failure; type 2 diabetes mellitus; ghrelin; gastrin; oxidative stress

Funding

  1. Juvenile Diabetes Research Foundation
  2. Human Islet Research Network of the NIH [DK104216]
  3. The Helmsley Charitable Trust
  4. European Union
  5. BIRAX
  6. DON foundation
  7. Israel Science Foundation
  8. I-CORE Program of The Israel Science Foundation (ISF) [41.11]
  9. Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative type 1 diabetes research project - JDRF
  10. USAID's American Schools and Hospitals Abroad Program for upgrading of the Hebrew University Medical School interdepartmental equipment unit
  11. Adams foundation
  12. Ariane de Rothschild Women Doctoral Program

Ask authors/readers for more resources

Beta cell failure is a central feature of type 2 diabetes (T2D), but the molecular underpinnings of the process remain only partly understood. It has been suggested that beta cell failure in T2D involves massive cell death. Other studies ascribe beta cell failure to cell exhaustion, due to chronic oxidative or endoplasmic reticulum stress leading to cellular dysfunction. More recently it was proposed that beta cells in T2D may lose their differentiated identity, possibly even gaining features of other islet cell types. The loss of beta cell identity appears to be driven by glucotoxicity inhibiting the activity of key beta cell transcription factors including Pdx1, Nkx6.1, MafA and Pax6, thereby silencing beta cell genes and derepressing alternative islet cell genes. The loss of beta cell identity is at least partly reversible upon normalization of glycemia, with implications for the reversibility of T2D, although it is not known if beta cell failure reaches eventually a point of no return. In this review we discuss current evidence for metabolism-driven compromised beta cell identity, key knowledge gaps and opportunities for utility in the treatment of T2D.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available